Tyvaso

Ended Awarded

Contract number
36C26024F0230
Awardee
Awarding agency
Obligated
$16,392

Award facts

Contract value 100% obligated
$16,391.56 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bartlett, TN 38134, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The contract is for the supply of Tyvaso (treprostinil) inhalation solution, a medication used to treat pulmonary arterial hypertension.

The contract, valued at $16,391.56, was awarded on February 15, 2024 and has a period of performance ending on January 31, 2025. It was issued against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. United Therapeutics also holds a $50 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center for the supply of several of its specialty pharmaceutical products, including Tyvaso. These contract vehicles enable the VA to efficiently procure United Therapeutics' medications for distribution to VA medical facilities across the country. No set-aside designation was used for this particular award.

Quick answers

Who was awarded contract 36C26024F0230?

36C26024F0230 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 20 (Veterans Health Administration) on February 15, 2024.

How much is contract 36C26024F0230 worth?

The government has obligated $16,392 on 36C26024F0230.

Is contract 36C26024F0230 an order under another contract?

Yes. 36C26024F0230 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26024F0230 competed?

The extent of competition for 36C26024F0230 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award